Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases

NCT04793737 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT04793737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04793737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases
Lead sponsor
Karolinska University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 8, 2021
Completion date
December 31, 2025
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma